Case number 3:18-cv-06112
MITSUBISHI TANABE PHARMA CORPORATION et al v. PRINSTON PHARMACEUTICAL INC. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 1, 2020 | 24 | Order (6) Docket Text: CONSENT JUDGMENT AND ORDER that this Court has jurisdiction over the parties and subject matter of these actions; the submission of the Aurobindo ANDA to the FDA for the purpose of obtaining regulatory approval to engage in the commercial manufacture, use and/or sale of the Aurobindo Product within the United States prior to the expiration of the 219 and 788 Patents was a technical act of patent infringement with respect to one or more claims of each of the 219 and 788 Patents; the claims of each of the 219 and 788 Patents are valid and enforceable solely with respect to the manufacture, use, sale, offer for sale, and importation of the Aurobindo Product in the United States; and Plaintiffs and Aurobindo waive all right to appeal or otherwise move for relief from this Judgment and Order. Signed by Chief Judge Freda L. Wolfson on 06/01/2020. (jdb) |
| Nov 4, 2019 | 23 | Scheduling Order (2) Docket Text: AMENDED SCHEDULING ORDER: Close of Expert Discovery due 1/10/2020; Submission of Final Pretrial Order due 2/27/2020; Final Pretrial Conference set for 3/10/2020; Trial set for 5/04/2020. Signed by Magistrate Judge Douglas E. Arpert on 11/04/2019. (jem) |
| Jun 14, 2019 | 22 | Order of Dismissal (5) Docket Text: CONSENT JUDGMENT AND ORDER dismissing case. Signed by Chief Judge Freda L. Wolfson on 6/14/2019. (jem) |
| Jun 12, 2019 | 21 | Letter (6) Docket Text: Letter from Plaintiffs to the Hon. Freda L. Wolfson, U.S.D.J.. (LIZZA, CHARLES) |
| May 28, 2019 | 20 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by KATHERINE ANNE DANIEL on behalf of MITSUBISHI TANABE PHARMA CORPORATION (DANIEL, KATHERINE) |
| Mar 26, 2019 | 19 | Order (3) Docket Text: ORDER Regarding Inventor Depositions and Fact Discovery. Fact Discovery shall close on 5/31/2019. Telephone Status Conference set for 4/24/2019 at 3:30 PM. Signed by Magistrate Judge Douglas E. Arpert on 3/25/2019. (mps) |
| Feb 7, 2019 | 18 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by COLLEEN TRACY JAMES on behalf of CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT LLC (JAMES, COLLEEN) |
| Oct 24, 2018 | 17 | Order (2) Docket Text: ORDER granting admission pro hac vice as to Hershy Stern, Esq. Signed by Magistrate Judge Douglas E. Arpert on 10/24/2018. (mmh) Modified on 11/14/2018 (eaj, ). |
| Jun 1, 2018 | 16 | Answer to Counterclaim (10) |
| Jun 1, 2018 | 16 | Certificate of Service (2) |
| Jun 1, 2018 | 16 | Main Document (10) Docket Text: ANSWER to Counterclaim by CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT LLC, MITSUBISHI TANABE PHARMA CORPORATION. (Attachments: # (1) Certificate of Service)(LIZZA, CHARLES) |
| May 11, 2018 | 13 | Answer to Complaint (18) Docket Text: ANSWER to Complaint , COUNTERCLAIM against CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT LLC, MITSUBISHI TANABE PHARMA CORPORATION by PRINSTON PHARMACEUTICAL INC..(CONROY, REBEKAH) |
| May 11, 2018 | 14 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by PRINSTON PHARMACEUTICAL INC. identifying Zhejiang Huahai Pharmaceutical Co., Ltd. as Corporate Parent.. (CONROY, REBEKAH) |
| May 11, 2018 | 15 | Order (2) Docket Text: ORDER CONSOLIDATING CASES FOR DISCOVERY AND CASE MANAGMENT. Civil Action No. 18-6112 is consolidated with Civil Action No. 17-5319 for discovery and case management purposes, the latter action having previously been consolidated with Civil Action Nos. 17-6375 and 17-12082 for discovery and case management purposes. All filings in the Consolidating Actions shall use the caption on this Order. Civil Action No. 17-5319 shall be the Lead Case and all filings going forward that are common to the Consolidated Actions shall be filed in Civil Action No. 17-53 19 only. all counsel who have been admitted pro hac vice in Civil Action No. 18-6112 shall be deemed to be admitted pro hac vice in Civil Action No. 17-5319. Signed by Magistrate Judge Douglas E. Arpert on 5/10/2018. (mps) |
| May 10, 2018 | 12 | Letter (3) Docket Text: Letter from Plaintiffs to the Hon. Douglas E. Arpert, U.S.M.J.. (LIZZA, CHARLES) |
| Apr 24, 2018 | 11 | Order (4) Docket Text: LETTER ORDER entering the schedule set herein. Counsel must submit a proposed order of consolidation by 5/10/2018. Telephone Status Conferences set for 6/13/2018 at 10:00AM, 9/10/2018 at 10:30AM, and 12/10/2018 at 10:00AM. Plaintiffs' Counsel to initiate the calls. Signed by Magistrate Judge Douglas E. Arpert on 4/24/2018. (km) |
| Apr 19, 2018 | 10 | Letter (4) Docket Text: Letter from Plaintiffs to the Hon. Douglas E. Arpert, U.S.M.J.. (LIZZA, CHARLES) |
| Apr 13, 2018 | 8 | Letter (4) Docket Text: Letter from Plaintiffs to the Hon. Douglas E. Arpert, U.S.M.J.. (LIZZA, CHARLES) |
| Apr 13, 2018 | 9 | Stipulation and Order (3) Docket Text: STIPULATION AND ORDER that Prinston shall answer or otherwise respond to the Complaint by 5/11/2018. Signed by Magistrate Judge Douglas E. Arpert on 4/13/2018. (km) |
| Apr 12, 2018 | N/A | Add and Terminate Judges (0) Docket Text: Judge Freda L. Wolfson and Magistrate Judge Douglas E. Arpert added. (jjc, ) |
| Apr 12, 2018 | 3 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to PRINSTON PHARMACEUTICAL INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *KIM STILLMAN* (kas, ) |
| Apr 12, 2018 | 4 | AO120 Patent/Trademark Form (1) Docket Text: AO120 Patent Form filed. (kas, ) |
| Apr 12, 2018 | 5 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by WILLIAM C. BATON on behalf of CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT LLC, MITSUBISHI TANABE PHARMA CORPORATION (BATON, WILLIAM) |
| Apr 12, 2018 | 6 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT LLC, MITSUBISHI TANABE PHARMA CORPORATION (SULLIVAN, SARAH) |
| Apr 12, 2018 | 7 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by DAVID LEIGH MOSES on behalf of CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT LLC, MITSUBISHI TANABE PHARMA CORPORATION (MOSES, DAVID) |
| Apr 11, 2018 | 1 | Complaint (128) |
| Apr 11, 2018 | 1 | Civil Cover Sheet (1) |
| Apr 11, 2018 | 2 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by CILAG GMBH INTERNATIONAL, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., JANSSEN RESEARCH AND DEVELOPMENT LLC, MITSUBISHI TANABE PHARMA CORPORATION. (LIZZA, CHARLES) |
| Apr 11, 2018 | 1 | Main Document (128) Docket Text: COMPLAINT against PRINSTON PHARMACEUTICAL INC. ( Filing and Admin fee $ 400 receipt number 0312-8635090), filed by MITSUBISHI TANABE PHARMA CORPORATION, JANSSEN RESEARCH AND DEVELOPMENT LLC, JANSSEN PHARMACEUTICA NV, JANSSEN PHARMACEUTICALS, INC., CILAG GMBH INTERNATIONAL. (Attachments: # (1) Civil Cover Sheet)(LIZZA, CHARLES) |
| Apr 11, 2018 | 1 | Complaint?* (1) |
